Caribou Biosciences
(NASDAQ:CRBU)
$5.12
0[0.00%]
Last update: 9:39AM Get Real Time Here
Consensus Rating1
Buy
Highest Price Target1
$24.00
Lowest Price Target1
$19.00
Consensus Price Target1
$24.33

Caribou Biosciences Stock (NASDAQ:CRBU), Analyst Ratings, Price Targets, Predictions

Caribou Biosciences Inc has a consensus price target of $24.33, established from looking at the 25 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., RBC Capital, and Cantor Fitzgerald on March 19, 2024, March 12, 2024, and November 8, 2023. With an average price target of $14.33 between HC Wainwright & Co., RBC Capital, and Cantor Fitzgerald, there's an implied 169.93% upside for Caribou Biosciences Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Nov 23
1
Mar
2
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
RBC Capital
Cantor Fitzgerald
Truist Securities
Oppenheimer

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Caribou Biosciences

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/19/2024CRBUBuy Now
Caribou Biosciences
$5.31351.98%HC Wainwright & Co.
Robert Burns
$23 → $24MaintainsBuyGet Alert
03/12/2024CRBUBuy Now
Caribou Biosciences
$5.31257.82%RBC Capital
Luca Issi
→ $19ReiteratesOutperform → OutperformGet Alert
11/08/2023CRBUBuy Now
Caribou Biosciences
$5.31Cantor Fitzgerald
Rick Bienkowski
Initiates → NeutralGet Alert
07/26/2023CRBUBuy Now
Caribou Biosciences
$5.31333.15%HC Wainwright & Co.
Robert Burns
$25 → $23MaintainsBuyGet Alert
07/14/2023CRBUBuy Now
Caribou Biosciences
$5.31333.15%Truist Securities
Asthika Goonewardene
$23 → $23ReiteratesBuy → BuyGet Alert
07/11/2023CRBUBuy Now
Caribou Biosciences
$5.31333.15%Truist Securities
Asthika Goonewardene
→ $23Initiates → BuyGet Alert
05/10/2023CRBUBuy Now
Caribou Biosciences
$5.31370.81%HC Wainwright & Co.
Robert Burns
$26 → $25MaintainsBuyGet Alert
03/14/2023CRBUBuy Now
Caribou Biosciences
$5.31389.64%HC Wainwright & Co.
Robert Burns
$27 → $26MaintainsBuyGet Alert
03/10/2023CRBUBuy Now
Caribou Biosciences
$5.31257.82%RBC Capital
Luca Issi
→ $19Reiterates → OutperformGet Alert
03/10/2023CRBUBuy Now
Caribou Biosciences
$5.31502.64%Oppenheimer
Mark Breidenbach
$36 → $32MaintainsOutperformGet Alert
08/29/2022CRBUBuy Now
Caribou Biosciences
$5.31615.63%Citigroup
Yigal Nochomovitz
$39 → $38MaintainsBuyGet Alert
08/18/2022CRBUBuy Now
Caribou Biosciences
$5.31408.47%HC Wainwright & Co.
Robert Burns
$28 → $27MaintainsBuyGet Alert
08/10/2022CRBUBuy Now
Caribou Biosciences
$5.31257.82%RBC Capital
Luca Issi
$22 → $19MaintainsOutperformGet Alert
05/13/2022CRBUBuy Now
Caribou Biosciences
$5.31634.46%Citigroup
Yigal Nochomovitz
$29 → $39MaintainsBuyGet Alert
05/12/2022CRBUBuy Now
Caribou Biosciences
$5.31540.3%SVB Leerink
Mani Foroohar
$30 → $34MaintainsOutperformGet Alert
05/10/2022CRBUBuy Now
Caribou Biosciences
$5.31464.97%SVB Leerink
Mani Foroohar
$29 → $30MaintainsOutperformGet Alert
03/22/2022CRBUBuy Now
Caribou Biosciences
$5.31446.14%SVB Leerink
Mani Foroohar
$32 → $29MaintainsOutperformGet Alert
02/18/2022CRBUBuy Now
Caribou Biosciences
$5.31314.31%RBC Capital
Luca Issi
→ $22Initiates → OutperformGet Alert
02/14/2022CRBUBuy Now
Caribou Biosciences
$5.31257.82%Brookline Capital
Leah Cann
→ $19Initiates → BuyGet Alert

FAQ

Q

What is the target price for Caribou Biosciences (CRBU)?

A

The latest price target for Caribou Biosciences (NASDAQ: CRBU) was reported by HC Wainwright & Co. on March 19, 2024. The analyst firm set a price target for $24.00 expecting CRBU to rise to within 12 months (a possible 368.75% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Caribou Biosciences (CRBU)?

A

The latest analyst rating for Caribou Biosciences (NASDAQ: CRBU) was provided by HC Wainwright & Co., and Caribou Biosciences maintained their buy rating.

Q

When was the last upgrade for Caribou Biosciences (CRBU)?

A

The last upgrade for Caribou Biosciences Inc happened on November 15, 2021 when Citigroup raised their price target to $27. Citigroup previously had a neutral for Caribou Biosciences Inc.

Q

When was the last downgrade for Caribou Biosciences (CRBU)?

A

There is no last downgrade for Caribou Biosciences.

Q

When is the next analyst rating going to be posted or updated for Caribou Biosciences (CRBU)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Caribou Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Caribou Biosciences was filed on March 19, 2024 so you should expect the next rating to be made available sometime around March 19, 2025.

Q

Is the Analyst Rating Caribou Biosciences (CRBU) correct?

A

While ratings are subjective and will change, the latest Caribou Biosciences (CRBU) rating was a maintained with a price target of $23.00 to $24.00. The current price Caribou Biosciences (CRBU) is trading at is $5.12, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch